TP53 and renal cell carcinoma: Specifically, Authors used the p53 D07 (DO7/DO-7) monoclonal antibody (mAb, which recognizes all types of mutant p53 [132]) to immunohistochemically determine the p53 expression in paraffin-embedded nephrectomy specimens from 175 RCC patients [131].